P25789 (PSA4_HUMAN) Homo sapiens (Human)

Proteasome subunit alpha type-4 UniProtKBInterProSTRINGInteractive Modelling

261 aa; Sequence (Fasta) ; (Isoform 2); 45 identical sequences

Available Structures

53 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
The human 26S Proteasome at 6.8 Ang. Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
1-261
Assess
HUMAN IMMUNOPROTEASOME 20S PARTICLE IN COMPLEX WITH [(1R)-2-(1-benzofuran-3-yl)-1-{[(1S,2R,4R)-7-ox… Heteromer
O14818; P20618; P25786; P25787; P25788; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
13×NA; 11×SCN;S5K;2-257
Assess
Human Constitutive 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-251
Assess
Crystal Structure of the mammalian 20S proteasome at 2.75 A resolution Heteromer
P33672; Q2TBP0; Q2TBX6; Q2YDE4; Q32KL2; Q3MHN0; Q3T0X5; Q3T0Y5; Q3T108; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
30×MG;2-251
Assess
Human constitutive 20S proteasome in complex with carfilzomib Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
3BV;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ADP;ATP;MG;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;2-251
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;2-251
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;ZN;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;MG;ADP;2-251
Assess
Cryo-EM structures and dynamics of substrate-engaged human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;ATP;ADP;2-251
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;2-251
Assess
Structural basis for dynamic regulation of the human 26S proteasome Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ATP;ZN;2-251
Assess
Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;2-251
Assess
SD-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;2-251
Assess
SA-like state of human 26S Proteasome with non-cleavable M1-linked hexaubiquitin and E3 ubiquitin l… Heteromer
A0A087X2I1; O00231; O00232; O00487; O14818; O43242; P0CG48; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;AGS;MG;ADP;2-251
Assess
Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Prot… Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ZN;2-251
Assess
The human 26S proteasome at 3.9 A Heteromer
O14818; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P49720; P49721; P60900; P62191; P62195; P62333; Q99436;
ATP;MG;ADP;2-251
Assess
Structure of the human 26S proteasome bound to USP14-UbAl Heteromer
O00231; O00232; O00487; O14818; O43242; P0CG47; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P54578; P55036; P60896; P60900; P62191; P62195; P62333; Q13200; Q15008; Q99436; Q99460; Q9UNM6;
ADP;2-251
Assess
Human Immunoproteasome 20S particle in complex with compound 1 Heteromer
O14818; P20618; P25786; P25787; P25788; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
SCN; 12×NA;HUJ;2-250
Assess
Native human 20S proteasome at 1.8 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
57×CL;1PE;K; 10×MG;2-249
Assess
Human 20S proteasome complex with Oprozomib at 1.9 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
58×CL;K; 10×MG;1PE;2-249
Assess
Human 20S proteasome complex with Delanzomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
52×CL;K; 10×MG;1PE;6V7;2-249
Assess
Human 20S proteasome complex with Ixazomib at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
51×CL;K; 10×MG;1PE;6V8;2-249
Assess
Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
56×CL;K; 10×MG;1PE;6VC;2-249
Assess
Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
55×CL;K; 10×MG;1PE;PHQ;2-249
Assess
Human 20S proteasome complex with Bortezomib at 2.1 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
51×CL;K; 10×MG;1PE;BO2;2-249
Assess
Human 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K; 10×MG;1PE;ACT;2-249
Assess
Native human 20S proteasome in Mg-Acetate at 2.2 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
K;MG;1PE;2-249
Assess
Human 20S proteasome complex with Epoxomicin at 2.4 Angstrom Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
58×CL;K; 10×MG;1PE;2-249
Assess
Endogeneous native human 20S proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-249
Assess
human PA200-20S complex Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
K0W;IHP;2-249
Assess
20S+monoUb-CyclinB1-NT (S1) Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
1-248
Assess
Akirin2 bound human proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q53H80; Q99436;
K;2-249
Assess
Human 20S Proteasome Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-248
Assess
20S+monoUb-CyclinB1-NT (S2) Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
2-248
Assess
PA28alpha-beta in complex with immunoproteasome Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
1-246
Assess
bovine 20S immunoproteasome Heteromer
P33672; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0;
1-246
Assess
Bovine 20S immunoproteasome in complex with two human PA28alpha-beta activators Heteromer
P33672; Q06323; Q2TBX6; Q2YDE4; Q3SZC2; Q3T0T1; Q3T0X5; Q3T0Y5; Q3T108; Q3T112; Q3ZBG0; Q3ZCK9; Q58DU5; Q5E987; Q5E9K0; Q9UL46;
1-246
Assess
Human 26S proteasome in complex with Oprozomib Heteromer
O00231; O00232; O00487; O14818; O43242; P17980; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P35998; P43686; P48556; P49720; P49721; P51665; P55036; P60896; P60900; P62191; P62195; P62333; Q15008; Q99436; Q99460; Q9UNM6;
ADP;2-245
Assess
Human 20S proteasome bound to an engineered 11S (PA26) activator Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436; Q9U8G2;
8-251
Assess
Structure of human 20S proteasome with bound MPI-5 Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
YHD;2-244
Assess
Cryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome core Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q99436;
KNM;2-244
Assess
Cryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively … Heteromer
O14818; P20618; P25786; P25787; P25788; P28062; P28065; P28066; P28070; P40306; P49720; P49721; P60900;
BZ7;2-241
Assess
Human 20S-PA200 Proteasome Complex Heteromer
O14818; P20618; P25786; P25787; P25788; P28066; P28070; P28072; P28074; P49720; P49721; P60900; Q14997; Q99436;
IHP;K0W;30-246
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.835gjq.1.S2-251
100.00
Assess

1 Homology model built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.865gjq.1.S1-180
100.00
Assess

Alignments